AML-derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition

MLA

Barzegar, Mohieddin, et al. “AML-Derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition.” Iranian Journal of Pharmaceutical Research : IJPR, vol. 20, no. 1, Jan. 2021, pp. 384–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4f6757152fe2f3b0a83fee63f4c2a71a&authtype=sso&custid=ns315887.

APA

Barzegar, M., Allahbakhshian Farsan, M., Amiri, V., Mohammadi, S., Shahsavan, S., Mirzaeian, A., & Mohammadi, M. H. (2021). AML-derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition. Iranian Journal of Pharmaceutical Research : IJPR, 20(1), 384–397.

Chicago

Barzegar, Mohieddin, Mehdi Allahbakhshian Farsan, Vahid Amiri, Saeed Mohammadi, Shaghayegh Shahsavan, Amin Mirzaeian, and Mohammad Hossein Mohammadi. 2021. “AML-Derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition.” Iranian Journal of Pharmaceutical Research : IJPR 20 (1): 384–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4f6757152fe2f3b0a83fee63f4c2a71a&authtype=sso&custid=ns315887.